Tech Company Financing Transactions

Jocasta Neuroscience Funding Round

On 8/12/2025, Jocasta Neuroscience raised $35 million in Series A financing from True Ventures, Moore Strategic Ventures and private investors.

Transaction Overview

Announced On
8/12/2025
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to support development of its lead a -- Klotho compound, JN-0413, through Phase 1 development (including both the Single Ascending Dose and Multiple Ascending Dose studies), with an IND submission slated for Q4 2026.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Scottsdale, AZ Undisclosed
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Jocasta is led by a team of dedicated entrepreneurs with a history in building groundbreaking biotech businesses that have changed millions of lives.
Profile
Jocasta Neuroscience LinkedIn Company Profile
Social Media
Jocasta Neuroscience Company Twitter Account
Company News
Jocasta Neuroscience News
Facebook
Jocasta Neuroscience on Facebook
YouTube
Jocasta Neuroscience on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Albert Agro
  Albert Agro LinkedIn Profile  Albert Agro Twitter Account  Albert Agro News  Albert Agro on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/12/2025: Dealops venture capital transaction
Next: 8/12/2025: Titan MSP venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary